Trial Profile
A Comparison of the Bioavailability of Rifabutin With and Without Lopinavir/Ritonavir in Healthy Adult Subjects.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2009
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir; Rifabutin
- Indications HIV infections; Mycobacterium avium complex infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 26 Jan 2009 Planned number of patients changed from 30 to 15 as reported by ClinicalTrials.gov.
- 26 Jan 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.